| Copper | Approved Investigational | ATP6V0D1 | 9114 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ATP6V0D1 mRNA | 16q22.1 | |
| Copper | Approved Investigational | ATP6V0D2 | 245972 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ATP6V0D2 mRNA | 8q21.3 | |
| Copper | Approved Investigational | ATP6V0E2 | 155066 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ATP6V0E2 mRNA | 7q36.1 | |
| Copper | Approved Investigational | ATP6V1C1 | 528 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ATP6V1C1 mRNA | 8q22.3 | |
| Copper | Approved Investigational | ATP6V1G1 | 9550 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ATP6V1G1 mRNA | 9q32 | |
| Copper | Approved Investigational | ATP7A | 538 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ATP7A mRNA | Xq21.1 | |
| Copper | Approved Investigational | ATP8A1 | 10396 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of ATP8A1 mRNA | 4p13 | |
| Copper | Approved Investigational | ATRIP | 84126 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of ATRIP mRNA | 3p21.31 | |
| Copper | Approved Investigational | ATXN1L | 342371 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of ATXN1L mRNA | 16q22.2 | |
| Copper | Approved Investigational | AURKA | 6790 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of AURKA mRNA | 20q13.2 | |
| Copper | Approved Investigational | AURKB | 9212 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of AURKB mRNA | 17p13.1 | |
| Copper | Approved Investigational | AVIL | 10677 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of AVIL mRNA | 12q14.1 | |
| Copper | Approved Investigational | AXL | 558 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of AXL mRNA | 19q13.2 | |
| Copper | Approved Investigational | B3GNT5 | 84002 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of B3GNT5 mRNA | 3q27.1 | |
| Copper | Approved Investigational | B3GNT7 | 93010 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of B3GNT7 mRNA | 2q37.1 | |
| Copper | Approved Investigational | B4GALT2 | 8704 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of B4GALT2 mRNA | 1p34.1 | |
| Copper | Approved Investigational | B4GAT1 | 11041 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of B4GAT1 mRNA | 11q13.2 | |
| Copper | Approved Investigational | BACE1 | 23621 |
upregulated | Copper results in increased expression of BACE1 mRNA | 11q23.3 | |
| Copper | Approved Investigational | BACH1 | 571 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BACH1 mRNA | 21q21.3 | |
| Copper | Approved Investigational | BAG1 | 573 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BAG1 mRNA | 9p13.3 | |
| Copper | Approved Investigational | BAG3 | 9531 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of BAG3 mRNA | 10q26.11 | |
| Copper | Approved Investigational | BARD1 | 580 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BARD1 mRNA | 2q35 | |
| Copper | Approved Investigational | BAX | 581 |
upregulated | Copper results in increased expression of BAX mRNA | 19q13.33 | |
| Copper | Approved Investigational | BBC3 | 27113 |
upregulated | Copper results in increased expression of BBC3 mRNA | 19q13.32 | |
| Copper | Approved Investigational | BBIP1 | 92482 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of BBIP1 mRNA | 10q25.2 | |